title: Pharmacokinetic and pharmacodynamic differences between nifedipine capsule and GITS formulations in hypertensive patients.
authors.forename: I
authors.initials: I
authors.lastname: Isordia
authors.forename: M
authors.initials: M
authors.lastname: Carrasco
authors.forename: A
authors.initials: A
authors.lastname: Chávez-Negrete
authors.forename: J A
authors.initials: JA
authors.lastname: Palma-Aguirre
authors.forename: F J
authors.initials: FJ
authors.lastname: Flores-Murrieta
authors.forename: G
authors.initials: G
authors.lastname: Castañeda-Hernández
mesh_terms: D001682:Biological Availability; D001794:Blood Pressure / Q000187:drug effects; D002121:Calcium Channel Blockers / Q000493:pharmacokinetics* / Q000494:pharmacology / Q000627:therapeutic use; D002214:Capsules; D003692:Delayed-Action Preparations; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D009200:Myocardial Contraction / Q000187:drug effects; D009543:Nifedipine / Q000493:pharmacokinetics* / Q000494:pharmacology / Q000627:therapeutic use; D012307:Risk Factors
chemical_list: D002121:Calcium Channel Blockers; D002214:Capsules; D003692:Delayed-Action Preparations; D009543:Nifedipine